| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H11N4O7P |
| Molar mass | 330.193 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Becampanel (INN; development codeAMP397) is aquinoxalinedionederivativedrug which acts as acompetitive antagonist of theAMPA receptor (IC50 = 11 nM).[1][2][3][4] It was investigated as ananticonvulsant for the treatment ofepilepsy byNovartis, and was also looked at as a potential treatment forneuropathic pain andcerebral ischemia, but never completedclinical trials.[1][2][3][5]
Thisanticonvulsant-related article is astub. You can help Wikipedia byadding missing information. |